Dr Rahul Ladwa, is an early career, full-time staff specialist in medical oncology at the Princess Alexandra Hospital, Brisbane. His undergraduate training was undertaken at the University of Leicester, England where his contribution to the study in oncogenes of the CCN family led to a Bachelor of Science (BSc) in 2007. He trained in medical oncology in Brisbane before undertaking a fellowship at the Royal Brisbane and Women’s Hospital, where he completed a higher research degree (MPhil) in the field of cancer imaging and theranostics with the University of Queensland. Here he has a conjoint role as a senior lecturer. Dr Ladwa is also a visiting clinical associate professor at the Queensland University of Technology. His interests include head & neck, lung and cutaneous malignancies. He is involved in clinical trials at the Princess Alexandra Hospital across these tumour streams. As a clinician in a tertiary medical oncology unit, he has conducted various phase clinical trials as a principal investigator and attracted significant research funding over $3,000,000 for an investigator sponsored research including the neoadjuvant use of immunotherapy in cutaneous malignancies. As an early career researcher, he has been involved in multi-collaborative research projects gaining funding as a principal investigator leading to multiple first author peer reviewed publications, oral presentations and conference abstracts. Recent collaborations include the study of HPV vaccine in oropharyngeal head and neck cancer, study the tumour microenvironment in cutaneous malignancies as well as cancer fatigue and frailty. He is on the supervisory team of students undergoing higher research degrees at UQ. He has attended national conferences as an invited speaker and chair.